# ZNF606

## Overview
ZNF606 is a gene that encodes the zinc finger protein 606, a member of the zinc finger protein family characterized by the presence of C2H2-type zinc finger domains and a Kruppel-associated box (KRAB) domain. These structural features enable the protein to function as a transcriptional regulator, primarily acting as a transcriptional repressor. Zinc finger protein 606 is involved in various cellular processes, including the modulation of gene expression related to cell growth, differentiation, and apoptosis. It plays a significant role in chondrocyte differentiation by interacting with the transcription factor Sox9, inhibiting its ability to bind to target gene enhancers, such as Col2a1, thereby suppressing Sox9-mediated transcriptional activity (Zhou2016ZNF606). The gene's expression and function have been implicated in several diseases, including glioma and colon cancer, where alterations in ZNF606 can influence disease progression and treatment response (McCleland2016CCAT1; Li2019Classification).

## Structure
ZNF606 is a zinc finger protein characterized by the presence of a Kruppel-associated box (KRAB) domain in its N-terminal region, which functions as a transcriptional repression domain (Zhou2016ZNF606; Guo2018Association). Zinc finger proteins typically contain C2H2-type zinc finger domains that facilitate DNA binding, and these domains are rich in cysteine and histidine residues. The primary structure of ZNF606 includes these characteristic residues, which contribute to its DNA-binding capability. The secondary structure of zinc finger proteins often includes alpha helices and beta sheets, which help stabilize the protein's conformation.

The tertiary structure of ZNF606 involves the folding of its zinc finger domains to form a stable, functional conformation. While zinc finger proteins generally do not form quaternary structures, the specific structural details of ZNF606's quaternary structure are not provided in the available context. Post-translational modifications such as phosphorylation and ubiquitination may affect the function and stability of ZNF606, although specific modifications for this protein are not detailed in the context. The existence of splice variant isoforms for ZNF606 is possible, leading to diverse functions, but specific isoforms are not mentioned in the provided information.

## Function
ZNF606 is a zinc finger protein that functions as a transcriptional regulator, primarily involved in modulating the transcriptional activity of other genes. It is known to interact with the transcription factor Sox9, a critical regulator of chondrocyte differentiation and cartilage formation. ZNF606 inhibits the transcriptional activity of Sox9 by reducing its ability to bind to the Col2a1 enhancer, a direct target gene of Sox9, thereby suppressing Sox9-mediated chondrocyte differentiation (Zhou2016ZNF606). This interaction suggests that ZNF606 acts as an inhibitor in the process of chondrocyte differentiation, which is crucial for cartilage development (Zhou2016ZNF606).

In addition to its role in chondrocyte differentiation, ZNF606 has been implicated in transcriptional repression activities in other cellular contexts. It contains a Kruppel-associated box domain, which is known to function as a transcriptional repression domain (Guo2018Association). The protein is typically active in the nucleus, where it influences the transcriptional landscape by binding to specific DNA sequences, thereby regulating gene expression involved in various cellular processes such as cell growth, differentiation, and apoptosis (Zhou2016ZNF606).

## Clinical Significance
ZNF606 has been implicated in various diseases due to its role in transcriptional regulation and interaction with other proteins. In glioma, particularly those with IDH mutations, alterations in ZNF606 expression and structure due to alternative splicing have been observed. These changes, especially deletions at the 3' end of zinc finger motifs, may contribute to the malignant progression of glioma, highlighting the clinical significance of ZNF606 in this context (Li2019Classification).

In the context of chondrocyte differentiation, ZNF606 interacts with the transcription factor Sox9, inhibiting its activity. This interaction affects the expression of chondrogenic genes, such as Col2a1, and plays a role in cartilage development. Alterations in ZNF606 expression or its interaction with Sox9 could impact chondrocyte differentiation, potentially affecting cartilage-related disorders (Zhou2016ZNF606).

ZNF606 is also associated with chromatin accessibility changes in mutant p53 tumors, where it is upregulated. This suggests a potential role in transcription regulation and chromatin function in these tumors, although the specific clinical implications remain unclear (Dhaka2021Differential).

In colon cancer, ZNF606 promoter methylation is linked to increased sensitivity to BET inhibitors, indicating its potential role in determining treatment response (McCleland2016CCAT1).

## Interactions
ZNF606 is known to interact with the transcription factor Sox9, which plays a crucial role in chondrocyte differentiation. This interaction is mediated through the C-terminal domains of both proteins. The study by Zhou et al. demonstrated that ZNF606 specifically interacts with Sox9 in cells, as shown by immunoprecipitation assays. The interaction was confirmed by ectopically expressing FLAG-tagged Sox9 in MCF-7 cells, where ZNF606 was identified as a co-immunoprecipitating protein (Zhou2016ZNF606).

ZNF606 inhibits the transcriptional activity of Sox9 by preventing its binding to the enhancers of target genes such as col2a1. This inhibition is significant because it suggests that ZNF606 acts as a negative regulator of Sox9-mediated transcriptional activity, which is essential for chondrocyte differentiation. The interaction between ZNF606 and Sox9 decreases during chondrocyte differentiation, indicating a dynamic regulatory role (Zhou2016ZNF606).

The study also found that ZNF606 does not affect the subcellular localization of Sox9 but specifically inhibits its DNA binding ability, further supporting its role as a transcriptional repressor in the context of chondrocyte differentiation (Zhou2016ZNF606).


## References


[1. (Zhou2016ZNF606) Zhenhai Zhou, Honggui Yu, Yunjia Wang, Qiang Guo, Longjie Wang, and Hongqi Zhang. Znf606 interacts with sox9 to regulate chondrocyte differentiation. Biochemical and Biophysical Research Communications, 479(4):920–926, October 2016. URL: http://dx.doi.org/10.1016/j.bbrc.2016.09.048, doi:10.1016/j.bbrc.2016.09.048. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2016.09.048)

[2. (Dhaka2021Differential) Bhavya Dhaka and Radhakrishnan Sabarinathan. Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours. BMC Cancer, June 2021. URL: http://dx.doi.org/10.1186/s12885-021-08362-x, doi:10.1186/s12885-021-08362-x. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-021-08362-x)

[3. (McCleland2016CCAT1) Mark L. McCleland, Kathryn Mesh, Edward Lorenzana, Vivek S. Chopra, Ehud Segal, Colin Watanabe, Benjamin Haley, Oleg Mayba, Murat Yaylaoglu, Florian Gnad, and Ron Firestein. Ccat1 is an enhancer-templated rna that predicts bet sensitivity in colorectal cancer. Journal of Clinical Investigation, 126(2):639–652, January 2016. URL: http://dx.doi.org/10.1172/jci83265, doi:10.1172/jci83265. This article has 181 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci83265)

[4. (Li2019Classification) Yaomin Li, Zhonglu Ren, Yuping Peng, Kaishu Li, Xiran Wang, Guanglong Huang, Songtao Qi, and Yawei Liu. Classification of glioma based on prognostic alternative splicing. BMC Medical Genomics, November 2019. URL: http://dx.doi.org/10.1186/s12920-019-0603-7, doi:10.1186/s12920-019-0603-7. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12920-019-0603-7)

[5. (Guo2018Association) Jingbin Guo, Qiushi Wang, Yangyang Liu, Lu Lu, Yue Hua, Rong Hu, Mingqing Wang, Zhiliang Li, Xianbao Wang, Bing Hui Wang, Qiang Fu, and Aihua Chen. Association of expression of znf606 gene from monocytes with the risk of coronary artery disease. Clinical Biochemistry, 60:44–51, September 2018. URL: http://dx.doi.org/10.1016/j.clinbiochem.2018.08.005, doi:10.1016/j.clinbiochem.2018.08.005. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.clinbiochem.2018.08.005)